Cosmos Pharmaceutical Corp Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cosmos Pharmaceutical Corp

Watchlist Manager

Watchlist

Price: 6 211 JPY 0.94%

Market Cap: ¥496.9B

	Cosmos Pharmaceutical Corp TSE:3349	JP
E	Expeditors International of Washington Inc DUS:EW1	US
	Schroders PLC LSE:SDR	UK
	Canada Goose Holdings Inc TSX:GOOS	CA
P	Pfizer Inc XHAM:PFE	US
	AGL Energy Ltd ASX:AGL	AU
N	Ninety One Ltd F:L91	ZA
	Align Technology Inc NASDAQ:ALGN	US
	Lynas Rare Earths Ltd OTC:LYSCF	MY
	Zotefoams PLC F:23Z	UK
E	Ecoener SA F:89W	ES
M	Marriott Vacations Worldwide Corp F:M8V	US
	International Paper Co LSE:IPC	US
H	Hilton Worldwide Holdings Inc F:HI91	US
P	Perusahaan Gas Negara Tbk PT F:PGB1	ID
A	Apple Inc F:APC	US

Profitability Summary

Cosmos Pharmaceutical Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

21%

Sustainable 3Y Average Gross Margin

20%

Gross Margin is Increasing

20% > 21%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

4% > 4%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

3% > 3%

Negative Free Cash Flow Margin

-1%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

1% > -1%

Positive ROE

12%

Positive 3Y Average ROE

Positive 3Y Average ROIC

10%

Declining ROIC

11% > 10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.